期刊文献+

乳腺癌微小钙化灶与C-erbB-2、ER、PR表达的相关性 被引量:2

Correlation Between Microcalcifications of Breast Cancer and the Expression of C-erbB-2,ER,PR in Breast Carcinoma
下载PDF
导出
摘要 目的探讨微小钙化灶的临床价值,评估乳腺癌人类上皮生长因子受体-2(C-erbB-2)、雌激素受体(ER)及孕激素受体(PR)异常表达与微小钙化的相关性。方法回顾性分析经X线检查、手术病理证实的91例乳腺癌患者,评估乳腺微小钙化灶诊断乳腺癌的准确率,按照ACR创立并推荐的BI-RADS,将X线所见钙化征象分为微小钙化组,中间型钙化组,无钙化组进行描述,并与C-erbB-2、ER及PR表达进行对照,分析其相关性。结果乳腺癌微小钙化灶与C-erbB-2的异常表达有显著相关性(P<0.05),而与ER、PR表达无明显相关性。结论乳腺癌微小钙化是其特征性表现,与C-erbB-2表达有一定关联性,可粗略预测C-erbB-2表达情况,并为判断肿瘤生物学行为及患者预后提供一定参考价值。 Objective To investigate the value of microcalcifications in breast and to assess the correlation between the malignant microealcifieations of breast cancer and the expression of C-erbB-2,ER,PR in breast carcinoma. Methods A retrospective study of 91 consecutive mammography patients with breast carcinomas was performed to evaluate microealci fications. Each patient was reviewed according to BI-RADS final assessment category system, the calcification was devided into malignant calcification, oseulant calcification and without calcifications. The expression of C-erbB-2, ER and PR was de tected with immunohistoehemical technique in breast cancer. Results The mammographic feature of breast cancer is mi crocalcifications. The C-erbB-2 positive expression was correlated with microcalcifications in breast carcinoma(P 〈0.05). Conclusion Malignant calcification of the breast carcinoma had a significant correlation with the expression of C-erbB-2. It is feasible to predict the expression of C-erbB-2 in breast carcinoma. So the biological behavior can be assessed by mammo graphic features ,which provide information for prognosis.
出处 《中南医学科学杂志》 CAS 2012年第6期559-562,共4页 Medical Science Journal of Central South China
基金 衡阳市科学技术局科技发展计划项目基金资助(2011KS27)
关键词 乳腺癌 钼靶X线摄影 人类上皮生长因子-2 雌激素受体 孕激素受体 breast carcinoma mammography C-erbB-2 esrtogen receptor progesterone receptor
  • 相关文献

参考文献11

  • 1American College of Radiology(ACR). Breast imaging re- porting and data system (BI-RADS) [ M ]. 3nd edition. Reston: American College of Radiology, 1998.1-19.
  • 2刘煌辉,王维,刘君,廖红荔,罗贤明,叶斌.乳腺癌钙化灶与ER、PR及c-erbB-2表达的关系[J].临床放射学杂志,2007,26(9):883-886. 被引量:16
  • 3Miehael PD. Clinical significance of HER-2/neu over ex- pression : Patti [ J ]. PrinciPles & Practise of Oncology, 1999,13(1) :11.
  • 4Cooke T, Reeves J, Lanigan A, et al. HER-2 as a prognos- tic and predictive marker for breast cancer[ J]. Annals of Oncology, 2001,12 ( Suppl. I ) : $23-$28.
  • 5陈蓉,龚水根,张伟国.乳腺癌分子水平的影像学研究进展[J].国外医学(临床放射学分册),2003,26(2):89-92. 被引量:25
  • 6Suthipintawong C, Wejaranayang C, Vipupinyo C. Prognos- tic significance of ER, PR, Ki-67, C-erbB-2, and p53 in endometrial carcinoma [ J]. J Med Assoc Thai, 2008,91 (12) : 1779-1784.
  • 7Srijaipracharoen S ,Tangjitgamol S ,Tanvanich S, et al. Ex- pression of ER, PR, and I-IER-2/neu in Endometrial Cancer:A Clinicopathological Study[ J]. Asian Pacific J Cancer Prev ,2010,11 ( 1 ) :215-220.
  • 8Goldhirsch A, Ingle JN, Gelber RD, et al. Thresholds for- therapies:highlights of the St Gallen International Expert- consensus on the primary therapy of early breast cancer [ J]. Ann 0ncol,2009,20(8) : 1319-1329.
  • 9Evans A J, Pinder SE, Ellis IO, et al. Correlations between the mammographic features of ductal carcinoma in situ (DClS) and C-erbB-2 oncogene expression[ J]. Clin Ra- diol, 1994,49 ( 8 ) :559-562.
  • 10Karamonis MV, Likakikaratza E, Ravazoula P, et al. Non- palpable breast carcinomas correlation of mammographi- cally decteted malignant appearing microcalcifications and molecular prognostic factors[ J]. Int J Cancer,2002, 102( 1 ) :86-90.

二级参考文献53

  • 1杨光,张祥宏,赵俊京,刘秀健,李智岗,王小玲,严霞,张志刚.乳腺癌钼靶X线微钙化与癌细胞ER、PR表达关系的研究[J].实用放射学杂志,2006,22(5):587-591. 被引量:30
  • 2KaramonisMV, Likaki-karatza E, Ravazoula P, et al. Non-palpable breast carcinomas correlation of mammographically decteted malignant-appearing microcalcifications and molecular prognostic factors[J]. Int J Cancer, 2002, 102(1 ) :86-90.
  • 3Vonrosen A, Wiege M, Tomberg B, et al. Relationship between certin radiographic and biologic characteristics in breast cancer [J]. Acta Oncol, 1987, 26:89-93.
  • 4Slamon D J, Leyland JB, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER-2 for metastatic breast cancer that overexpresses HER-2 [J]. N Engl J Med, 2001, 344:783-792.
  • 5Norberg T, Klaar S, Karf G, et al. Increased p53 nutation frequency during tumor progression-resuhs from a breast cancer cohort[J]. Cancer Res, 2001,61:8317-8321.
  • 6Moriki T, Takahashi T, Hirio M, et al. Histological grade in invasive ductal carcinoma of breast correlates with the proliferative activity evaluared by Brdu: an study including correlation with p.53 C-erbB-2 and estrogen receptor status [J]. Pathol Int, 1996, 46:417-421.
  • 7Montero S, Guzman C, Vargas C, et al. Prognostic value of cytosolic p53 protein in breast cancer[ J ]. Tumor Biol, 2001,22: 337-341.
  • 8Sickles E.Breast imaging:from 1965 to the present.Radiology,2000,215(1):1-16
  • 9Williams MB,Pisano ED,Schnall MD,et al.Future directions in imaging of breast diseases.Radiology,1998,206(2):297-300
  • 10Weissleder R.Molecular imaging:exploring the next frontier.Radiology,1999,212(3):609-614

共引文献40

同被引文献30

  • 1赵俊卿,李云峰,杨之斌.肿瘤细胞发生细胞上皮-间质转变机制的研究[J].肿瘤,2010,30(10):890-893. 被引量:27
  • 2Machado P, Eisenbrey JR, Cavanaugh B, et al. New image processing technique for evaluating breast microcalcifica- tions : a comparative study [ J ]. J Ultrasound Med, 2012, 31(6) :885-893.
  • 3Sayeed A,Konduri SD,Liu W,et al.Estrogen receptor alpha inhibits p53-mediated transcriptional repression:implications for the regulation of apoptosis[J].Cancer Res,2007,67(16):7746-7755.
  • 4Girault I,Bieche I,Lidereau R.Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer[J].Maturitas,2006,54(4):342-351.
  • 5Lupien M,Eeckhoute J,Meyer CA,et al.Coactivator function defines the active estrogen receptor alpha cistrome[J].Mol Cell Biol,2009,29(12):3413-3423.
  • 6Qi C,Chang J,Zhu Y,et al.Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha[J].J Biol Chem,2002,277(32):28624-28630.
  • 7Meyer R,Wolf SS,Obendorf M.PRMT2,a member of the protein arginine methyltransferase family,is a coactivator of the androgen receptor[J].J Steroid Biochem Mol Biol,2007,107(1-2):1-14.
  • 8Yoshimoto T,Boehm M,Olive M,et al.The arginine methyltransferase PRMT2 binds RB and regulates E2F function[J].Exp Cell Res,2006,312(11):2040-2053.
  • 9Blythe SA,Cha SW,Tadjuidje E,et al.beta-Catenin primes organizer gene expression by recruiting a histone H3 arginine 8 methyltransferase,Prmt2[J].Dev Cell,2010,19(2):220-231.
  • 10Ganesh L,Yoshimoto T,Moorthy NC,et al.Protein methyltransferase 2 inhibits NF-{kappa}B function and promotes apoptosis[J].Mol Cell Biol,2006,26(10):3864-3874.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部